Betadine vs Sterile Water for Periurethral Preparation

NCT07044726 — Phase 4, Recruiting, 148 participants, University of Louisville

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Betadine vs Sterile Water for Periurethral Preparation Prior to Straight Catherization in the Clinic Setting: A Randomized Controlled Trial

RegistryNCT07044726
StatusRecruiting
PhasePhase 4
Study typeInterventional; randomized, parallel, masking: single, prevention
Enrollment148 (Estimated)
SponsorUniversity of Louisville (Other)
ConditionsCatherization, Urinary Tract Infection Bacterial
InterventionsPovidone-Iodine, Sterile water (Drug)
Datesstart 2025-06-30, primary completion 2028-05-21 (estimated), completion 2028-05-21 (estimated), first posted 2025-07-01, last updated 2026-05-04
Locations2 sites in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Catherization All trials for Urinary Tract Infection Bacterial All trials of Povidone-Iodine All trials of Sterile water

-Summary

The purpose of this study is to determine whether cleaning of the urethra, or external opening to the bladder, with sterile water (water that has been treated to remove bacteria and living organisms) vs Betadine also known as Povidone-Iodine (a medical grade cleaning solution) changes the rates of bacteria in the urine after a temporary catheter, or draining tube, is placed into the bladder. Chemical antiseptics, including Betadine, are the current standard of care. An additional goal of this study is to determine whether cleaning of the urethra, or external opening to the bladder, with sterile water vs betadine changes the amount of discomfort or pain patients experience with placement of a temporary catheter, or draining tube, in the bladder.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
BetadineActive comparatorDrug: Povidone-IodineBetadine periurethral preparation
Sterile WaterSham comparatorDrug: Sterile waterSterile Water periurethral preparation
  • Povidone-Iodine (Drug): Providone-Iodine for periurethral preparation
  • Sterile water (Drug): Sterile water for periurethral preparation

+Outcome measures

Primary outcomes

  • Bacteruria [Within 2 weeks of the patients procedure date]: Bacteruria defined as the presence of bacteria within patient urine evaluated with urinalysis. Bacterial presence will be further characterized by colony forming unit count on urine culture.

Secondary outcomes

  • Urethral Pain [At the time of catherization]: Urethral pain at the time of catheterization rated by patients on a visual analog scale zero to ten with zero representing no pain and ten representing the worst pain of their life.

+Eligibility

Sex: Female, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* Aged 18+
* Patient undergoing in office straight catherization

Exclusion Criteria:

* History of culture proven recurrent urinary tract infection (2 in any 6-month period or 3 in any 12-month period)
* Urine Analysis with +Nitrites
* Catherization for any reason in the last 4 weeks
* History of Iodine allergy
* Patients unable to speak English
* Patient does not have the capacity to consent
* 2-3rd trimester pregnancy

+Locations (2)

FacilityCityCountryStatus
UofL Physicians - Urogynecology Springs Urogynecology OfficeLouisville, KentuckyUnited StatesRecruiting
UofL Health - Urogynecology Mary & Elizabeth Hospital, Medical Plaza 3Louisville, KentuckyUnited StatesRecruiting

+Study documents

+Investigators